a b c
d e f
g h i
j k l
m n o
p q r s
t u v
w x y z
|
Product |
Code |
Section |
|
DAB Tablets |
NCL-DAB |
Secondary Detection Systems and Reagents |
|
DAB Substrate Kit, Liquid |
NCL-L-DAB |
Secondary Detection Systems and Reagents |
|
DAB Enhancing Solution, Novostain |
NCL-DAB-En |
Secondary Detection Systems and Reagents |
|
Daxx |
NCL-DAXX |
Cell Cycle Associated Markers |
|
Deleted in Colorectal Cancer Protein |
NCL-DCC |
Oncosuppressor and Associated Proteins |
|
Deleted in Pancreatic Cancer Locus 4 Protein |
NCL-DPC4 |
Oncosuppressor and Associated Proteins |
|
Delta-Sarcoglycan |
NCL-d-SARC |
Muscle Disease |
|
Desmin |
NCL-DES-DERII |
Small and Intermediate Filaments |
|
Desmin (Liquid Primary Antibody) |
NCL-L-DES-DERII |
Small and Intermediate Filaments |
|
Desmin (Ready to Use) |
RTU-DES-DERII |
Small and Intermediate Filaments |
|
Dinitrophenyl |
NCL-DNP |
Secondary Detection Systems and Reagents |
|
DNA Fragmentation Factor (DFF) (N-terminus) |
NCL-DFFp |
Cell Cycle Associated Markers |
|
Dysferlin |
NCL-Hamlet |
Muscle Disease |
|
Dysferlin |
NCL-Hamlet-2 |
Muscle Disease |
|
Dystroglycan (Beta) |
NCL-b-DG |
Muscle Disease |
|
Dystrophin |
NCL-DYSA |
Muscle Disease |
|
Dystrophin |
NCL-DYSB |
Muscle Disease |
|
Dystrophin (Rod domain) |
NCL-DYS1 |
Muscle Disease |
|
Dystrophin (C-terminus) |
NCL-DYS2 |
Muscle Disease |
|
Dystrophin (N-terminus) |
NCL-DYS3 |
Muscle Disease |
|
Dystrophin Antibodies (duo pack) |
NCL-DYS1/2 |
Muscle Disease |
|
Dystrophin Antibodies (triple pack) |
NCL-DYS1/2/3 |
Muscle Disease |
|
Dystrophin Kit |
NCL-DYS-Frozen |
Immunohistochemistry Systems |